ORLY
52
5
PAYX
45
6
TRV
42
5
EA
44
3
SYF
83
7
HCA
39
2
VTR
46
3
ICE
55
2
HPQ
57
2
NTAP
60
2
D
35
2
FIS
48
5
BXP
41
3
IPG
42
2
BEN
40
3
WAT
59
4
RHI
50
2
FLR
52
2
MRK
27
2
FAST
44
3
ORLY
52
5
PAYX
45
6
TRV
42
5
EA
44
3
SYF
83
7
HCA
39
2
VTR
46
3
ICE
55
2
HPQ
57
2
NTAP
60
2
D
35
2
FIS
48
5
BXP
41
3
IPG
42
2
BEN
40
3
WAT
59
4
RHI
50
2
FLR
52
2
MRK
27
2
FAST
44
3
Financhill
Back

Acumen Pharmaceuticals 10K Form

Sell
11

ABOS
Acumen Pharmaceuticals

Last Price:
$1.80
Seasonality Move:
-0.33%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ABOS News And Ratings

See the #1 stock for the next 7 days that we like better than ABOS

ABOS Financial Statistics

Sales & Book Value

Annual Sales: $1.4M
Cash Flow: $-24.6M
Price / Cash Flow: 0
Annual Sales: $3.62
Price / Book: 0.5

Profitability

EPS (TTM): -1.38000
Net Income (TTM): $-81.7M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Acumen Pharmaceuticals Earnings Forecast

Key Acumen Pharmaceuticals Financial Ratios

  • The Interest Expense is -1.11% of Operating Income.
  • Per Share Earnings over the last 5 years have been positive in 2 years.

Acumen Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ABOS
Website: acumenpharm.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ABOS Technical Analysis vs Fundamental Analysis

Sell
11
Acumen Pharmaceuticals (ABOS) is a Sell

Is Acumen Pharmaceuticals a Buy or a Sell?